Ovo Lasik + Lens
Saint Louis Park, Minnesota, 55416, United States
NCT Number: NCT07087665
This study is a single-site, single-arm, prospective, observational study of subject satisfaction, quality of vision, and quality of life after bilateral LASIK surgery. Subjects will be assessed 6 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the adapted PROWL, QIRC, and OSDI questionnaires.
Looking for future studies?
Notify Me18 year–37 year
All sexes
Observational
Saint Louis Park, Minnesota, 55416, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The WaveLight EX500 laser system, in conjunction with INNOVEYES Sightmap, is indicated for use in INNOVEYES Laser Assisted In-Situ Keratomileusis ("wavelight plus"1 LASIK) treatments:
Time frame: 6 months postoperatively
Time frame: 6 months postoperatively
Time frame: 6 months postoperatively
Time frame: 6 months postoperatively
OVO LASIK + Lens
Other
Patient Satisfaction, Quality of Vision, and Quality of Life Following Treatment With WaveLight Plus LASIK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06700460
Eye Diseases, Myopia
Omaha, Nebraska, United States
View Trial DetailsNCT03334253
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial DetailsNCT00320593
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial DetailsNCT06758076
Eye Diseases, Hyperopia
Manchester, United Kingdom
View Trial Details